Design and delivery of selective inhibitors of tumor-overexpressed isozymes of carbonic anhydrase-towards new theranostic systems for cancer detection and treatment
Başlık çevirisi mevcut değil.
- Tez No: 401523
- Danışmanlar: DR. MARC A. ILIES
- Tez Türü: Doktora
- Konular: Eczacılık ve Farmakoloji, Pharmacy and Pharmacology
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 2014
- Dil: İngilizce
- Üniversite: Temple University
- Enstitü: Yurtdışı Enstitü
- Ana Bilim Dalı: Belirtilmemiş.
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: 147
Özet
Özet yok.
Özet (Çeviri)
Cancer is the second most common cause of death and a major cause of mortality in the world. The high mortality associated with cancer is due to the fact that usually it is discovered too late, when it is metastasized to different organs and is very hard to cure. Finding more efficient, convenient and selective ways for early diagnosis and eradication of pre-malignant or malignant tumors of small dimensions is a task of utmost importance. The development of many malignant tumors was associated with hypoxia and the over-expression of specific membrane-bound carbonic anhydrase (CA) isozymes CA IX and CA XII. Malignant tissue of relatively small dimensions can grow fast and can invade the surrounding tissues by reverting to anaerobic metabolism and by acidifying the extracellular milieu around the tumor, increasing its invasiveness. Our goal is to detect and treat malignant hypoxic tumors using selective inhibitors of CA IX and CA XII and the objective of this thesis was to develop selective and efficient carbonic anhydrase inhibitors (CAIs) for the tumoral CA IX and CA XII that will leave unaltered the normal tissues. Two new sets of membrane-impermeant carbonic anhydrase inhibitors are proposed to be developed based on pyridinium positively-charged moieties attached to know CAI pharmacophores. Our guiding hypothesis was that modulation of carbonic anhydrase potency and tissue penetrability is possible to be achieved via fine tuning of pyridinium substitution. The use of appropriate substitutents on the pyridinium ring allowed the creation of CAI with special optical properties (e.g. fluorescence). The rationale for the research summarized in this thesis was that a CAI selective for membrane isozymes CA IX and CA XII over-expressed in cancer with controlled tissue penetrability can open new avenues in cancer early detection and treatment that will complement and/or potentiate present technologies and therapies.
Benzer Tezler
- PLGA-kurkumin nano-formülasyonunun kanser hücrelerinde NF-kB'nin p65 alt birimi düzeyi üzerindeki etkisinin incelenmesi
Investigation of the effect of PLGA-curcumin nano- formulation on the p65 sub-unit level of NF-kBb in cancer cell lines
ŞEYMA BULUT
Yüksek Lisans
Türkçe
2021
BiyoteknolojiBezm-i Alem Vakıf ÜniversitesiBiyoteknoloji Ana Bilim Dalı
DR. ÖĞR. ÜYESİ FATEMEH BAHADORİ
DOÇ. DR. PINAR OBAKAN YERLİKAYA
- Fibrosarkoma tedavisine yönelik STAT3 inhibitörü içeren nanopartiküler ilaç taşıyıcı sistem formülasyonlarının geliştirilmesi ve İn Vitro-İn Vivo değerlendirilmesi
Development and In Vitro-In Vivo evaluation of nanoparticular drug delivery system formulations containing STAT3 inhibitor for fibrosarcoma treatment
HATİCE DEMİRTAŞ
Doktora
Türkçe
2025
Eczacılık ve FarmakolojiAnkara ÜniversitesiFarmasötik Teknoloji Ana Bilim Dalı
PROF. DR. CEYDA TUBA ŞENGEL TÜRK
- Akciğer kanserine yönelik tirozin kinaz inhibitörü taşıyıcı lipit-polimer hibrit nanopartiküllerin geliştirilmesi, karakterizasyonu ve ın vitro etkinliğinin değerlendirilmesi
Development, characterization and in vitro evaluation of tyrosine kinase inhibitor carrier lipid-polymer hybrid nanoparticles for lung cancer
PELİNSU KORUCU
Doktora
Türkçe
2024
Eczacılık ve FarmakolojiHacettepe ÜniversitesiFarmasötik Teknoloji Ana Bilim Dalı
PROF. DR. BETÜL ARICA YEGİN
DOÇ. DR. İPEK BAYSAL
- Characterization of liposomal Celecoxib formulation as a drug delivery system in colorectal cancer cell lines
Ilaç taşıyıcı sistem olarak lipozomal Celecoxib formülasyonunun kolorektal kanser hücrelerinde karakterizasyonu
ASLI ERDOĞ
Doktora
İngilizce
2012
BiyoteknolojiOrta Doğu Teknik ÜniversitesiBiyoteknoloji Ana Bilim Dalı
DOÇ. DR. AYŞEN TEZCANER
YRD. DOÇ. DR. SREEPARNA BANERJEE
- İnterlökin-1 inhibitörü ilaç adayı yeni 5-(triflorometoksi) -1h-indol-2,3-dion 3-(4-feniltiyosemikarbazon) türevlerinin tasarımı, sentezi ve etkinliklerinin incelenmesi
Design, synthesis and investigation of activities of interleukin-1 inhibitor drug candidate new 5-(trifluoromethoxy)-1h-indole-2,3-dione 3-(4-phenylthiosemicarbazone) derivatives
ÖZGE SOYLU
Doktora
Türkçe
2019
Eczacılık ve Farmakolojiİstanbul ÜniversitesiFarmasötik Kimya Ana Bilim Dalı
PROF. DR. NİLGÜN LÜTFİYE KARALI